These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8014788)

  • 21. Dosing problems in the use of topical ophthalmic drops.
    Loewenstein A; Geyer O; Blanc A; Lazar M
    Graefes Arch Clin Exp Ophthalmol; 1992; 230(4):378-9. PubMed ID: 1505772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alternative mydriasis techniques for retinopathy of prematurity screening.
    Seliniotaki AK; Prousali E; Lithoxopoulou M; Kokkali S; Ziakas N; Soubasi V; Mataftsi A
    Int Ophthalmol; 2020 Dec; 40(12):3613-3619. PubMed ID: 32772218
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mydriatic insert and intracameral injections compared with mydriatic eyedrops in cataract surgery: controlled studies.
    Behndig A; Korobelnik JF
    J Cataract Refract Surg; 2015 Jul; 41(7):1503-19. PubMed ID: 26287888
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of mydriatic eye drops on wavefront sensing with the Zywave aberrometer.
    Taneri S; Oehler S; Azar DT
    J Refract Surg; 2011 Sep; 27(9):678-85. PubMed ID: 21446641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of efficacy and tolerance between 1% hydroxyamphetamine plus 0.25% tropicamide (Paremyd) and 0.5% tropicamide combined with 2.5% phenylephrine.
    Zeise MM; McDougall BW; Bartlett JD; Corliss D; Mitten L
    J Am Optom Assoc; 1996 Nov; 67(11):681-9. PubMed ID: 8979662
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of phenylephrine 2.5% versus phenylephrine 10% on pupillary dilation in patients with diabetes.
    Weiss JS; Weiss JN; Greenfield DS
    Retina; 1995; 15(2):130-3. PubMed ID: 7624600
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The comparison of mydriatic effect between two drugs of different mechanism.
    Park JH; Lee YC; Lee SY
    Korean J Ophthalmol; 2009 Mar; 23(1):40-2. PubMed ID: 19337478
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomised controlled pilot trial comparing low dose and very low- dose microdrop administration of phenylephrine and cyclopentolate for retinopathy of prematurity eye examinations in neonates.
    Kremer LJ; Broadbent R; Medlicott N; Sime MJ; McCaffrey F; Reith DM
    Arch Dis Child; 2021 Jun; 106(6):603-608. PubMed ID: 33051215
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of a new preoperative ophthalmic solution.
    Hirowatari T; Tokuda K; Kamei Y; Miyazaki Y; Matsubara M
    Can J Ophthalmol; 2005 Feb; 40(1):58-62. PubMed ID: 15825531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systemic adverse events after screening of retinopathy of prematurity with mydriatic.
    Obata S; Imamura T; Kakinoki M; Yanagi T; Maruo Y; Ohji M
    PLoS One; 2021; 16(9):e0256878. PubMed ID: 34499693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ophthalmic Insert versus Eye Drops for Mydriasis in Neonates: A Randomized Clinical Trial.
    Bremond-Gignac D; Jacqz-Aigrain E; Abdoul H; Daruich A; Beresniak A; Baud O; Alberti C;
    Neonatology; 2019; 115(2):142-148. PubMed ID: 30481790
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effective pupil dilatation with a mixture of 0.75% tropicamide and 2.5% phenylephrine: A randomized controlled trial.
    Trinavarat A; Pituksung A
    Indian J Ophthalmol; 2009; 57(5):351-4. PubMed ID: 19700872
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The pain response to mydriatic eyedrops in preterm infants.
    Cohen AM; Cook N; Harris MC; Ying GS; Binenbaum G
    J Perinatol; 2013 Jun; 33(6):462-5. PubMed ID: 23238569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A combination solution for routine pupillary dilation.
    Krumholz DM; Portello JK; Rosenfield M; Rosenbaum JD
    Optometry; 2006 Jul; 77(7):350-3. PubMed ID: 16814239
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of a mydriatic spray in the pediatric population.
    Benavides JO; Satchell ER; Frantz KA
    Optom Vis Sci; 1997 Mar; 74(3):160-3. PubMed ID: 9159806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative study of the effects of 2% ibopamine, 10% phenylephrine, and 1% tropicamide on the anterior segment.
    Marchini G; Babighian S; Tosi R; Perfetti S; Bonomi L
    Invest Ophthalmol Vis Sci; 2003 Jan; 44(1):281-9. PubMed ID: 12506086
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A pupillographic evaluation of a phenylephrine HCl 5%-tropicamide 0.8% combination mydriatic.
    Kergoat H; Lovasik JV; Doughty MJ
    J Ocul Pharmacol; 1989; 5(3):199-216. PubMed ID: 2625616
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Single dose of 1% tropicamide and 10% phenylephrine for pupil dilation.
    Ratanapakorn T; Yospaiboon Y; Chaisrisawadsuk N
    J Med Assoc Thai; 2006 Nov; 89(11):1934-9. PubMed ID: 17205877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of 2% ibopamine on the dilation of patients with pseudoexfoliation syndrome.
    Scuderi GL; Regine F; Perdicchi A; Turtoro A; Contestabile MT
    Eur J Ophthalmol; 2010; 20(1):120-3. PubMed ID: 19882519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of the single-drop mydriatic combination of 0.8% tropicamide with 5% phenylephrine with multiple applications of the same drop: a randomized controlled trial.
    Jethani J; Solanki H; Nayak A
    Indian J Ophthalmol; 2011; 59(4):323-5. PubMed ID: 21666324
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.